Biogen has filed a new drug application to Japan’s regulator for the approval of aducanumab, its investigational treatment for Alzheimer’s disease, which it is developing together...
UK digital health firm Sensyne has secured access to millions more anonymised patent records via an alliance with The post Sensyne launches fundraising, agrees patient data...
California Sees Record 30K+ New COVID Cases; Fauci Says US Won't Return To Normal Until Mid-2021: Live Updates Tyler Durden Wed, 12/09/2020 - 15:58 Summary: Normaity...
Longenesis announces the first deployment of its flagship product Curator for real-time, privacy-preserving biomedical data identification, with National Research Programme in Latvia for COVID-19 research acceleration...
Canada 3rd To Approve Pfizer Jab; UAE Says Sinopharm COVID Vaccine 86% Effective: Live Updates Tyler Durden Wed, 12/09/2020 - 11:21 Summary: Canada approves Pfizer vaccine...
Canada Latest To Approve Pfizer Jab; UAE Says Sinopharm COVID Vaccine 86% Effective: Live Updates Tyler Durden Wed, 12/09/2020 - 11:21 Summary: Canada approves Pfizer vaccine...
After clinical trials showed no major side effects with Pfizer’s COVID vaccine, the U.K. is attaching a new warning after severe allergic reactions in two patients...
Reviewers from the FDA have given their blessing to the Pfizer/BioNTech COVID-19 vaccine ahead of a key meeting The post FDA reviewers back Pfizer/BioNTech COVID-19 vaccine...
Facts - Not Fear - Will Stop The Pandemic Tyler Durden Tue, 12/08/2020 - 20:05 Authored by Dr. Jayanta Bhattacharya via The American Institute for Economic...
U.S. coronavirus cases crossed the 15 million mark on Dec. 8 as regulators moved a step closer to approving a Covid-19 vaccine and Britain started inoculating...
U.S. regulators moved a step closer to approving a Covid-19 vaccine as Britain started inoculating people, offering hope of slowing a pandemic that killed 15,000 Americans...
COVID-19 vaccine testing on children is just getting started, and only in adolescents. It may be fall before one is approved for kids.
You may be surprised to learn that of the trio of long-awaited coronavirus vaccines, the most promising, Moderna’s mRNA-1273, which reported a 94.5 percent efficacy rate...
Johnson & Johnson could obtain late-stage trial results of the company's Covid-19 vaccine earlier than expected, according to J&J chief scientist Paul Stoffels.
Pfizer Inc. cleared the next hurdle in the race to get the company's Covid-19 vaccine approved for emergency use after the U.S. Food and Drug Administration...
Though the White House is planning on hosting a “Vaccine Summit” on Tuesday, two major players will not be attending. Pfizer and Moderna have both reportedly...
Shares of Qiagen rose almost 3% in Tuesday’s pre-market trading after the medical diagnostics company lifted its financial outlook for 2020 and 2021. Qiagen (QGEN) said...
The prototype of a lung sound recording system developed at TU Graz (Austria) allows high-quality recordings of lung sounds, which can be used to more objectively...
We could start making our genomes equipped to deal with more frequent pandemics. But it may come at a cost.
We could start making our genomes equipped to deal with more frequent pandemics. But it may come at a cost.
Bureaucracy, political upheaval, and lack of regulations continue to make Latin America a difficult market for European and The post Latin America: How pharma can navigate...
China’s Sinovac has raised $515 million to increase its distribution and production capacity as clinical development of its The post Sinovac raises $515m to boost production...
Pfizer CEO "Not Certain" Vaccine Will Stop People From Spreading COVID-19 Tyler Durden Fri, 12/04/2020 - 12:45 By Joseph Jankowski of PlanetFreeWill, Just one day after...
In November, global equities saw their biggest ever monthly rise: +12.2% for the MSCI AC World index in US dollars (dataset since 1988). Encouraging news on...
Moderna Inc. expects to have between 100 million and 125 million doses of the company's Covid-19 vaccine available globally in the first quarter of 2021.
Credit: Georgia State University ATLANTA–Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours, researchers in the...
The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just...
This is the question that a recent paper by Chorniy et al. (2020) attempt to answer. This issue is clearly very relevant as the UK recently...
AstraZeneca Plc will likely get results of the company's U.S. Covid-19 vaccine trial in late January 2021 and could potentially file for an emergency authorization, the...
Health inequalities are a long-term condition and inclusive research is the only disease modifying therapy in the pipeline The post Inclusive research and tackling health inequalities...